Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MYO |
---|---|---|
09:32 ET | 3156 | 5.1 |
09:48 ET | 133 | 5.1475 |
09:51 ET | 100 | 5.15 |
09:53 ET | 400 | 5.11 |
09:55 ET | 400 | 5.15 |
09:57 ET | 600 | 5.14 |
10:00 ET | 200 | 5.14 |
10:04 ET | 100 | 5.15 |
10:06 ET | 1400 | 5.15 |
10:13 ET | 17278 | 5.215 |
10:15 ET | 100 | 5.215 |
10:18 ET | 3818 | 5.25 |
10:20 ET | 4261 | 5.25 |
10:22 ET | 1721 | 5.22 |
10:24 ET | 6773 | 5.2 |
10:29 ET | 200 | 5.25 |
10:31 ET | 600 | 5.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Myomo Inc | 154.0M | -22.8x | --- |
Jin Medical International Ltd | 165.9M | 44.0x | +21.92% |
KORU Medical Systems Inc | 161.4M | -13.9x | --- |
SANUWAVE Health Inc | 177.6M | -213.1x | --- |
Pro-Dex Inc | 152.4M | 31.9x | -9.17% |
Senseonics Holdings Inc | 187.3M | -2.3x | --- |
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $154.0M |
---|---|
Revenue (TTM) | $25.2M |
Shares Outstanding | 30.2M |
Myomo Inc does not pay a dividend. | |
Beta | 1.66 |
EPS | $-0.23 |
Book Value | $0.33 |
P/E Ratio | -22.8x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -33.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.